tiprankstipranks
Trending News
More News >
Chia Tai Enterprises International (HK:3839)
:3839

Chia Tai Enterprises International (3839) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Chia Tai Enterprises International

(OTC:3839)

Rating:62Neutral
Price Target:
HK$6.50
▲(9.24%Upside)
Chia Tai Enterprises International's score is driven by strong financial performance in terms of revenue growth and profitability, despite cash flow challenges. The technical analysis indicates strong momentum, though caution is warranted due to overbought signals. Valuation suggests the stock is attractively priced, enhancing its appeal despite the lack of earnings call and corporate events data.

Chia Tai Enterprises International (3839) vs. iShares MSCI Hong Kong ETF (EWH)

Chia Tai Enterprises International Business Overview & Revenue Model

Company DescriptionChia Tai Enterprises International (3839) is a multinational conglomerate operating primarily in the agriculture and consumer goods sectors. The company is engaged in the production and distribution of various agricultural products, including animal feed, seeds, and fertilizers. Additionally, it is involved in the manufacturing and sale of consumer goods, with a focus on providing high-quality products to enhance agricultural productivity and consumer lifestyle.
How the Company Makes MoneyChia Tai Enterprises International generates revenue through a diversified business model that includes the sale of agricultural products such as animal feed, seeds, and fertilizers. The company leverages its extensive distribution network to reach farmers and agricultural businesses, ensuring a steady demand for its products. Additionally, the company's involvement in the consumer goods sector allows it to tap into the retail market, offering a range of products that cater to household needs. Strategic partnerships with local and international businesses also play a crucial role in expanding its market reach and enhancing its revenue streams. The company's earnings are further supported by its commitment to innovation and product development, which helps maintain its competitive edge in the industry.

Chia Tai Enterprises International Financial Statement Overview

Summary
Chia Tai Enterprises International shows strong revenue growth and improving profit margins, indicating positive operational momentum. The solid balance sheet with low leverage reflects financial stability. However, significant risks remain due to the absence of positive cash flow, highlighting a need for improved cash management.
Income Statement
70
Positive
Chia Tai Enterprises International has shown a strong revenue growth rate with a significant increase from 2023 to 2024. The gross profit margin stands at 15.90% for 2024, depicting healthy profitability. Additionally, the net profit margin improved to 3.63%, indicating better cost management and operational efficiency. However, there is room for improvement in EBIT and EBITDA margins, which suggest potential for enhanced operational performance.
Balance Sheet
65
Positive
The company's debt-to-equity ratio is 0.29, reflecting a conservative approach to leverage and strong equity financing. The equity ratio is 55.60%, indicating a robust financial position with a substantial portion of assets financed by equity. Return on Equity (ROE) is modest at 4.76% for 2024, suggesting average returns for shareholders. There is a need to enhance asset utilization and profitability to boost ROE.
Cash Flow
50
Neutral
Chia Tai Enterprises International faces challenges in cash flow management, as evidenced by no reported operating or free cash flow for 2024. The absence of positive cash flow suggests potential liquidity constraints. Historically, the company has struggled with consistent free cash flow generation, highlighting the need for improved cash flow efficiency and cost control.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue307.75M173.98M159.24M142.41M93.58M
Gross Profit48.93M33.77M39.19M34.76M24.90M
EBITDA17.51M11.29M5.17M20.86M23.73M
Net Income11.17M2.55M-4.26M26.70M16.25M
Balance Sheet
Total Assets422.21M377.37M350.58M365.22M330.70M
Cash, Cash Equivalents and Short-Term Investments32.38M37.61M30.86M31.09M32.26M
Total Debt69.17M78.17M49.10M42.61M20.50M
Total Liabilities161.70M125.36M94.83M81.69M80.09M
Stockholders Equity234.77M228.43M230.85M253.06M228.00M
Cash Flow
Free Cash Flow-2.56M-27.17M-10.38M-28.46M-9.23M
Operating Cash Flow11.29M-16.06M5.63M-10.91M4.03M
Investing Cash Flow-9.27M-7.14M-15.64M-9.84M-10.87M
Financing Cash Flow-7.07M30.23M10.38M19.36M249.00K

Chia Tai Enterprises International Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.95
Price Trends
50DMA
2.12
Positive
100DMA
1.87
Positive
200DMA
1.66
Positive
Market Momentum
MACD
0.69
Negative
RSI
96.09
Negative
STOCH
97.92
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3839, the sentiment is Positive. The current price of 5.95 is above the 20-day moving average (MA) of 2.69, above the 50-day MA of 2.12, and above the 200-day MA of 1.66, indicating a bullish trend. The MACD of 0.69 indicates Negative momentum. The RSI at 96.09 is Negative, neither overbought nor oversold. The STOCH value of 97.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3839.

Chia Tai Enterprises International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
HK$736.89M7.138.81%5.75%5.79%-43.49%
70
Outperform
HK$793.12M10.0910.50%14.93%-8.64%-25.13%
62
Neutral
HK$1.51B10.847.60%124.78%889.01%
60
Neutral
HK$19.93B11.900.81%5.34%2.72%-47.45%
55
Neutral
HK$337.53M47.620.55%10.00%-66.75%-83.83%
49
Neutral
HK$279.38M-40.39%-43.73%-434.56%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3839
Chia Tai Enterprises International
5.95
5.21
704.05%
HK:3737
Zhongzhi Pharmaceutical Holdings Limited
0.86
-0.20
-18.87%
HK:0239
Pak Fah Yeow International Limited
2.52
0.27
12.00%
HK:1652
Fusen Pharmaceutical Co., Ltd.
0.38
-0.67
-63.81%
HK:0897
Wai Yuen Tong Medicine Holdings Limited
0.30
0.12
66.67%

Chia Tai Enterprises International Corporate Events

Chia Tai Enterprises International Secures Shareholder Approval for Key Resolutions at AGM
Jun 10, 2025

Chia Tai Enterprises International Limited announced the successful passage of all proposed resolutions during its Annual General Meeting held on June 10, 2025. These resolutions included the re-election of directors, the authorization of the board to fix directors’ remuneration, the re-appointment of KPMG as auditors, and the adoption of a new share option scheme. The approval of these resolutions signifies strong shareholder support and positions the company for continued strategic governance and operational flexibility.

Chia Tai Enterprises Approves Revised Annual Caps at Special General Meeting
Jun 10, 2025

Chia Tai Enterprises International Limited announced the successful passing of a proposed resolution during their Special General Meeting held on June 10, 2025. The resolution, concerning the Proposed Revised 2025 and 2026 Annual Caps of continuing connected transactions, was approved unanimously by the votes cast. This decision reflects the company’s ongoing commitment to aligning its operations with strategic financial goals, potentially impacting its market positioning and shareholder interests positively.

Chia Tai Enterprises Reports Strong Q1 2025 Results
May 15, 2025

Chia Tai Enterprises International Limited reported a significant increase in its unaudited consolidated results for the first quarter of 2025, with revenue rising to US$165,041,000 from US$54,654,000 in the same period of 2024. The company’s profit before tax also saw a substantial increase, reaching US$11,579,000 compared to US$1,876,000 in the previous year. This growth reflects improved operational performance and a positive impact on the company’s financial health, benefiting both shareholders and non-controlling interests.

Chia Tai Enterprises Announces Special General Meeting for Revised Financial Caps
May 9, 2025

Chia Tai Enterprises International Limited has announced a special general meeting to be held on June 10, 2025, in Hong Kong. The meeting aims to approve revised annual caps for transactions under the 2023 Master HOEL Purchase Agreement, with new maximum aggregate annual values set at US$506.1 million for 2025 and US$556.7 million for 2026. This adjustment reflects the company’s strategic financial planning and could impact its operational budget and stakeholder expectations.

Chia Tai Enterprises Announces Delay in Circular Dispatch
May 7, 2025

Chia Tai Enterprises International Limited has announced a delay in the dispatch of a circular related to the Proposed Revised 2025 and 2026 Annual Caps. The circular, which includes recommendations and advice for shareholders, was initially expected by May 9, 2025, but will now be dispatched by May 13, 2025, due to the time required for printing.

Chia Tai Enterprises to Review Q1 2025 Financial Results
May 2, 2025

Chia Tai Enterprises International Limited has announced that its board of directors will convene on May 15, 2025, to approve the unaudited financial results for the first quarter of 2025. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the year.

Chia Tai Enterprises Schedules AGM to Discuss Key Financial and Governance Matters
Apr 25, 2025

Chia Tai Enterprises International Limited has announced its upcoming Annual General Meeting (AGM) to be held on June 10, 2025, in Hong Kong. The meeting will address several key agenda items, including the adoption of the company’s financial statements for 2024, the re-election of directors, and the re-appointment of KPMG as auditors. Additionally, the board seeks approval to issue new shares, which could potentially impact the company’s capital structure and shareholder value.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 08, 2025